Aldose reductase inhibitor obtained from Crucibulum sp. RF-3817

Details Aldose reductase inhibitor obtained from Crucibulum sp. RF-3817 Aldose reductase inhibitor obtained from Crucibulum sp. RF-3817

1991-05-08

1994-06-28

Brust, Joseph Paul

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548430, 435184, 435119, C07D491048, A61K 3140, C12P 1718, C12N 999

Patent

active

053247426

ABSTRACT:
The present invention relates to a novel aldose reductase inhibitor of the formula: ##STR1## wherein X is methylene or carbonyl;

REFERENCES:
patent: 3812112 (1974-05-01), Kimura et al.
patent: 4337265 (1982-06-01), Treasurywala et al.
patent: 4503236 (1985-03-01), Unangst
patent: 4695571 (1987-09-01), Melvin
Sarges, Advances in Drug Research, vol. 18, pp. 139-175 (1989).
Horhammer et al, Arch. Pharm., vol. 292, pp. 113-125 (1959).

Affiliated with

Also associated with

Rating

Aldose reductase inhibitor obtained from Crucibulum sp. RF-3817 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aldose reductase inhibitor obtained from Crucibulum sp. RF-3817, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldose reductase inhibitor obtained from Crucibulum sp. RF-3817 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2377638